Chemed (CHE)
(Delayed Data from NYSE)
$597.42 USD
-6.75 (-1.12%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $597.86 +0.44 (0.07%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CHE 597.42 -6.75(-1.12%)
Will CHE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
Here's Why You Should Retain Chemed (CHE) Stock for Now
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
Other News for CHE
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS completes purchase of assets in Florida, Alabama
Analysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
Chemed Corp Executive Vice President Spencer Lee Sells Company Shares